Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Aug;64(2):379–380. doi: 10.1038/bjc.1991.312

The prognostic value of the monoclonal antibody (D5) detected protein, p29, in primary colorectal carcinoma.

J F Robertson 1, D L Morris 1, I O Ellis 1, N C Armitage 1, J D Hardcastle 1
PMCID: PMC1977535  PMID: 1892769

Full text

PDF
379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage N. C., Robins R. A., Evans D. F., Turner D. R., Baldwin R. W., Hardcastle J. D. The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg. 1985 Oct;72(10):828–830. doi: 10.1002/bjs.1800721018. [DOI] [PubMed] [Google Scholar]
  2. Cano A., Coffer A. I., Adatia R., Millis R. R., Rubens R. D., King R. J. Histochemical studies with an estrogen receptor-related protein in human breast tumors. Cancer Res. 1986 Dec;46(12 Pt 1):6475–6480. [PubMed] [Google Scholar]
  3. Coffer A. I., Milton P. J., Pryse-Davies J., King R. J. Purification of oestradiol receptor from human uterus by affinity chromotrgraphy. Mol Cell Endocrinol. 1977 Feb;6(4-5):231–246. doi: 10.1016/0303-7207(77)90098-3. [DOI] [PubMed] [Google Scholar]
  4. Estival A., Mouniélou P., Trocheris V., Scemama J. L., Clemente F., Hollande E., Ribet A. Presence of VIP receptors in a human pancreatic adenocarcinoma cell line. Modulation of the cAMP response during cell proliferation. Biochem Biophys Res Commun. 1983 Mar 29;111(3):958–963. doi: 10.1016/0006-291x(83)91393-1. [DOI] [PubMed] [Google Scholar]
  5. Harrison J. D., Morris D. L., Ellis I. O., Jones J. A., Jackson I. The effect of tamoxifen and estrogen receptor status on survival in gastric carcinoma. Cancer. 1989 Sep 1;64(5):1007–1010. doi: 10.1002/1097-0142(19890901)64:5<1007::aid-cncr2820640506>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  6. Heyderman E., Ebbs S. R., Larkin S. E., Brown B. M., Haines A. M., Bates T. Response of breast carcinoma to endocrine therapy predicted using immunostained pelleted fine needle aspirates. Br J Cancer. 1989 Oct;60(4):630–633. doi: 10.1038/bjc.1989.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. King R. J., Coffer A. I., Gilbert J., Lewis K., Nash R., Millis R., Raju S., Taylor R. W. Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium. Cancer Res. 1985 Nov;45(11 Pt 2):5728–5733. [PubMed] [Google Scholar]
  8. Leake R. E., Laing L., Calman K. C., Macbeth F. R. Estrogen receptors and antiestrogen therapy in selected human solid tumors. Cancer Treat Rep. 1980 Jun-Jul;64(6-7):797–799. [PubMed] [Google Scholar]
  9. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  10. McClendon J. E., Appleby D., Claudon D. B., Donegan W. L., DeCosse J. J. Colonic neoplasms: tissue estrogen receptor and carcinoembryonic antigen. Arch Surg. 1977 Mar;112(3):240–241. doi: 10.1001/archsurg.1977.01370030012002. [DOI] [PubMed] [Google Scholar]
  11. Sica V., Nola E., Contieri E., Bova R., Masucci M. T., Medici N., Petrillo A., Weisz A., Molinari A. M., Puca G. A. Estradiol and progesterone receptors in malignant gastrointestinal tumors. Cancer Res. 1984 Oct;44(10):4670–4674. [PubMed] [Google Scholar]
  12. Viguerie N., Tahiri-Jouti N., Esteve J. P., Clerc P., Logsdon C., Svoboda M., Susini C., Vaysse N., Ribet A. Functional somatostatin receptors on a rat pancreatic acinar cell line. Am J Physiol. 1988 Jul;255(1 Pt 1):G113–G120. doi: 10.1152/ajpgi.1988.255.1.G113. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES